METHODS	Forty-five patients with non-cholestatic laparoscopy-biopsy proven HCV-associated chronic hepatitis ( n = 16 ) or cirrhosis ( n = 29 ) who had not responded to , or were unsuitable for IFN , were randomly assigned to receive UDCA ( 600 mg/day ; n = 23 ) or no therapy ( n = 22 ) for 12 months .\